Research News

1/14/19

University at Buffalo researchers have received a $2.7 million grant from the National Institutes of Health to continue their study of health outcomes among members of the military.

12/20/18

Steven J. Fliesler, PhD, SUNY Distinguished Professor and the Meyer H. Riwchun Endowed Chair Professor of ophthalmology, has been awarded a $2.2 million grant from the National Eye Institute of the National Institutes of Health to better understand a rare cause of blindness that strikes young children.

12/18/18

New stem cell research led by Fraser J. Sim, PhD, associate professor of pharmacology and toxicology, has identified novel therapeutic targets for the treatment of multiple sclerosis (MS) and other inflammatory diseases.

12/17/18

Nonprescription use of Ritalin may cause irreversible structural changes in certain areas of the brain, according to researchers in the Department of Pharmacology and Toxicology and UB’s Clinical and Research Institute on Addictions (CRIA).

12/12/18

Two Jacobs School of Medicine and Biomedical Sciences researchers have found that college students expended more effort, time and money to obtain their smartphones than they did for food, according to results from a paper in Addictive Behaviors.

12/11/18

Jennifer A. Martin, a doctoral student in the Department of Pharmacology and Toxicology, has received a prestigious Blueprint Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience Award from the National Institutes of Health (NIH).

12/6/18

Research by Richard M. Gronostajski, PhD, professor of biochemistry, reveals that the absence of one copy of a single gene in the brain causes a rare, as-yet-unnamed neurological disorder.

12/5/18

The National Institutes of Health is funding researchers in the Department of Pharmacology and Toxicology to study the effects of drinking, smoking and marijuana use during pregnancy.

11/29/18

Pinaki Sarder, PhD, assistant professor of pathology and anatomical sciences, is using funding from the National Institutes of Health to refine development of computational tools to quantify renal structures in human diabetic nephropathy (DN) biopsies.

11/20/18

Cytocybernetics, a UB spinoff founded by two Jacobs School of Medicine and Biomedical Sciences faculty members, has received a $250,000 Small Business Innovation Research award from the National Institute of Mental Health (NIMH) to move into a new market: neuronal drug development.

11/19/18

The recipients of this year’s Dean’s and Nader Research Fellowships have a wide range of research interests and knowledge.

11/13/18

Andrew H. Talal, MD, professor of medicine in the Division of Gastroenterology, Hepatology and Nutrition, has been appointed to New York Gov. Andrew M. Cuomo’s task force that will advise the state on its Hepatitis C Virus (HCV) Elimination Campaign.

11/8/18

Research led by Jonathan F. Lovell, PhD, associate professor of biomedical engineering, has provided a breakthrough in efforts to boost the efficacy of malarial transmission-blocking vaccines (TBV).

11/1/18

Research by Yun Wu, PhD, assistant professor of biomedical engineering, has led to a cancer-spotting tool that health care providers could eventually use in areas that lack hospitals, clinics and other treatment centers.

10/30/18

A study published in JAMA Pediatrics that rigorously assessed how the home environments of young children who are genetically at high risk for obesity can influence whether they become overweight or obese is being praised by University at Buffalo child obesity experts.